moxonidine and Postoperative Complications studies

moxonidine and Postoperative Complications

moxonidine: structure given in first source

Postoperative Complications: Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.

Research Excerpts

Excerpt	Relevance	Reference
"Treatment with moxonidine is associated with less AF recurrences after ablation treatment for drug-refractory AF in patients with hypertension."	5.19	Central sympathetic inhibition to reduce postablation atrial fibrillation recurrences in hypertensive patients: a randomized, controlled study. ( Deftereos, S; Doudoumis, K; Efremidis, M; Giannopoulos, G; Katsivas, A; Kossyvakis, C; Letsas, K; Manolis, AS; Panagopoulou, V; Pyrgakis, V; Raisakis, K; Rentoukas, I; Stefanadis, C; Tousoulis, D, 2014)

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

0 (0.00)

29.6817

2010's

1 (100.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Giannopoulos, G	1
Kossyvakis, C	1
Efremidis, M	1
Katsivas, A	1
Panagopoulou, V	1
Doudoumis, K	1
Raisakis, K	1
Letsas, K	1
Rentoukas, I	1
Pyrgakis, V	1
Manolis, AS	1
Tousoulis, D	1
Stefanadis, C	1
Deftereos, S	1

Studies

Giannopoulos, G

Kossyvakis, C

Efremidis, M

Katsivas, A

Panagopoulou, V

Doudoumis, K

Raisakis, K

Letsas, K

Rentoukas, I

Pyrgakis, V

Manolis, AS

Tousoulis, D

Stefanadis, C

Deftereos, S

Clinical Trials (1)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
Pharmacologic Suppression of Central Sympathetic Activity for Prevention of Atrial Fibrillation Recurrence After Pulmonary Vein Isolation (MOXAF)[NCT01791699]	Phase 4	150 participants (Anticipated)	Interventional	2012-08-31	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial

Phase

Enrollment

Study Type

Start Date

Status

Pharmacologic Suppression of Central Sympathetic Activity for Prevention of Atrial Fibrillation Recurrence After Pulmonary Vein Isolation (MOXAF)[NCT01791699]

Phase 4

150 participants (Anticipated)

Interventional

2012-08-31

Completed

[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for moxonidine and Postoperative Complications

Article	Year
Central sympathetic inhibition to reduce postablation atrial fibrillation recurrences in hypertensive patients: a randomized, controlled study. Circulation, 2014, Oct-14, Volume: 130, Issue:16 Topics: Aged; Antihypertensive Agents; Atrial Fibrillation; Catheter Ablation; Double-Blind Method; Female;	2014

Article

Year

Central sympathetic inhibition to reduce postablation atrial fibrillation recurrences in hypertensive patients: a randomized, controlled study.

Circulation, 2014, Oct-14, Volume: 130, Issue:16

Topics: Aged; Antihypertensive Agents; Atrial Fibrillation; Catheter Ablation; Double-Blind Method; Female;

2014